Luis Malpica

Epidemiology, clinical features, and outcome of HTLV-1–related ATLL in an area of prevalence in the United States

Luis Malpica, Agustin Pimentel, Isildinha M. Reis et al. · Blood Advances · 2018 · 105 citations · Full text

Medicine, Hematology, Oncology +13

Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study

Yuqin Song, Luis Malpica, Qingqing Cai et al. · The Lancet Oncology · 2023 · 55 citations

Medicine, Oncology, Pharmacology +13

Epstein–Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship

L. Jeffrey Medeiros, Mario L. Marques‐Piubelli, Valentina Sangiorgio et al. · Modern Pathology · 2021 · 43 citations · Full text

Medicine, Immunology, Oncology +14

Real-World Data on Adult T-Cell Leukemia/Lymphoma in Latin America: A Study From the Grupo de Estudio Latinoamericano de Linfoproliferativos

Luis Malpica, Daniel Enríquez, Denisse Castro et al. · JCO Global Oncology · 2021 · 32 citations · Full text

Medicine, Immunology, Oncology +14

<i>DUSP22</i> rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma

Lianqun Qiu, Guilin Tang, Shaoying Li et al. · Haematologica · 2022 · 31 citations · Full text

Medicine, Oncology, Pathology +13